PET and SPECT reporter gene imaging

Molecular Imaging Probes for Cancer Research

Volumn , Issue , 2012, Pages 373-415

  Yaghoubi, Shahriar S ^a,b  

^a CellSight Technologies   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY;

REPORTER GENE;

MOLECULAR PHYSICS;

EID: 84906864805     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9789814293686_0013     Document Type: Chapter

References (190)

1. Gambhir SS, Barrio JR, Phelps ME, Iyer M, Namavari M, Satyamurthy N, et al. Imaging adenoviral- directed reporter gene expression in living animals with positron emission tomography. PNAS. 1999; 96: 2333–2338.
2. Gambhir SS, Barrio J, Wu L, Iyer M, Namavari M, Satyamurthy N, et al. Imaging of adenoviral directed herpes simplex virus type 1 thymidine kinase gene expression in mice with ganciclovir. J Nucl Med. 1998; 39: 2003–2011.
3. Tjuvajev JG, Finn R, Watanabe K, Joshi R, Oku T, Kennedy J, et al. Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: a potential method for monitoring clinical gene therapy. Cancer Res. 1996; 56: 4087–4095.
4. Tjuvajev JG, Avril N, Oku T, Sasajima T, Miyagawa T, Joshi R, et al. Imaging Herpes virus thymidine kinase gene transfer and expression by positron emission tomography. Cancer Res. 1998; 58: 4333–4341.
5. Tjuvajev JG, Chen SH, Joshi A, Joshi R, Guo ZS, Balatoni J, et al. Imaging adenoviralmediated herpes virus thymidine kinase gene transfer and expression in vivo. Cancer Res. 1999; 59: 5186–5193.
6. Gambhir SS. Imaging gene expression: concepts and Future Outlook. In: Schiepers C, editor. Diagnostic nuclear medicine. New York: Springer-Verlag Berlin Heidelberg; 1999. p. 253–271.
7. Gambhir SS, Barrio JR, Herschman HR, Phelps ME. Imaging gene expression: principles and assays. J Nucl Cardiol. 1999; 6: 219–233.
8. Gambhir SS, Barrio JR, Herschman HR, Phelps ME. Assays for noninvasive imaging of reporter gene expression. Nucl Med Biol. 1999; 26: 481–490.
9. De A, Gambhir SS. PET in imaging gene expression and therapy. In: Bailey D, Townsend D, Valk P, Maisey M, eds. Positron Emission Tomography: Basic Science and Clinical Practice. Springer-Verlag; 2003. p. 845–868.
10. Gambhir SS, Bauer E, Black ME, Liang Q, Kokoris MS, Barrio JR, et al. A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography. PNAS. 2000; 97: 2785–2790.
11. Likar Y, Dobrenkov K, Olszewska M, Shenker L, Cai S, Hricak H, et al. PET imaging of HSV1-tk mutants with acquired specificity toward pyrimidine- and acycloguanosine-based radiotracers. Eur J Nucl Med Mol Imaging. 2009; 36: 1273–1282.
12. Likar Y, Dobrenkov K, Olszewska M, Vider E, Shenker L, Cai S, et al. A new acycloguanosine- specific supermutant of herpes simplex virus type 1 thymidine kinase suitable for PET imaging and suicide gene therapy for potential use in patients treated with pyrimidine-based cytotoxic drugs. J Nucl Med. 2008; 49: 713–720.
13. Iyer M, Barrio JR, Namavari M, Bauer E, Satyamurthy N, Nguyen K, et al. 8-[18F] Fluoropenciclovir: an improved reporter probe for imaging HSV1-tk reporter gene expression in vivo using PET. J Nucl Med. 2001; 42: 96–105.
14. Namavari M, Barrio J, Toyokuni T, Gambhir S, Cherry S, Herschman H, et al. Synthesis of 8-[18F]Fluoroguanine derivatives: in vivo probes for imaging gene expression with positron emission tomography. Nucl Med Biol. 2000; 27: 157–162.
15. Hsieh C, Chen F, Wang H, Hwang J, Chang C, Lee Y, et al. Generation of destabilized herpes simplex virus type 1 thymidine kinase as transcription reporter for PET reporter systems in molecular-genetic imaging. J Nucl Med. 2008; 49: 142–150.
16. Min J, Iyer M, Gambhir SS. Comparison of [18F]FHBG and [14C]FIAU for imaging of HSV1-tk reporter gene expression: adenoviral infection vs stable transfection. Eur J Nucl Med Mol Imaging. 2003; 30: 1547–1560.
17. Green LA, Nguyen K, Berenji B, Iyer M, Bauer E, Barrio JR, et al. A tracer kinetic model for 18F-FHBG for quantitating herpes simplex virus type 1 thymidine kinase reporter gene expression in living animals using PET. J Nucl Med. 2004; 45: 1560–1570.
18. Alauddin MA, Shahinian A, Gordon EM, Bading JR, Conti PS. Preclinical evaluation of the penciclovir analog 9-(4-[18F]fluoro-3-hydroxymethylbutyl)guanine for in vivo measurement of suicide gene expression with PET. J Nucl Med. 2001; 42: 1682–1690.
19. Alauddin MA, Shahinian A, Gordon EM, Conti PS. Direct comparison of radiolabeled probes FMAU, FHBG, and FHPG as PET imaging agents for HSV1-tk expression in human breast cancer model. Mol Imaging. 2004; 3: 76–84.
20. Alauddin MM, Conti PS. Synthesis and preliminary evaluation of 9-(4-[18F]-Fluoro-3- Hydroxymethylbutyl)Guanine ([18F]FHBG): a new potential imaging agent for viral infection and gene therapy using PET. Nucl Med Biol. 1998; 25: 175–180.
21. Hsieh C, Liu R, Wang H, Hwang J, Deng W, Chen J, et al. In vitro evaluation of herpes simplex virus type 1 thymidine kinase reporter system in dynamic studies of transcriptional gene regulation. Nucl Med Biol. 2006; 33.
22. Yaghoubi SS, Barrio JR, Dahlbom M, Iyer M, Namavari M, Satyamurthy N, et al. Human pharmacokinetic and dosimetry studies of [18F]FHBG: a reporter probe for imaging herpes simplex virus type-1 thymidine kinase reporter gene expression. J Nucl Med. 2001; 42: 1225–1234.
23. Yaghoubi SS, Couto MA, Chen C, Polavaram L, Cui G, Sen L, et al. Preclinical safety evaluation of 18F-FHBG: a PET reporter probe for imaging herpes simplex virus type 1 thymidine kinase (HSV1-tk) or mutant HSV1-sr39tk’s expression. J Nucl Med. 2006; 47: 706–715.
24. Penuelas I, Boan JF, Marti-Climent JM, Barajas MA, Narvaiza I, Satyamurthy N, et al. A fully automated one pot synthesis of 9-(4-[18F]Fluoro-3-Hydroxymethylbutyl)Guanine for gene therapy studies. Mol Imaging Biol. 2003; 4: 415–424.
25. Ponde DE, Dence CS, Schuster DP, Welch MJ. Rapid and reproducible radiosynthesis of [18F]FHBG. Nucl Med Biol. 2004; 31: 133–138.
26. Shiue GG, Shiue C, Lee RL, MacDonald D, Hustinx R, Eck SL, et al. A simplified one-pot synthesis of 9-[(3-[18F]Fluoro-1-hydroxy-2-propoxy)methyl]guanine ([18F]FHPG) and 9-(4- [18F]Fluoro-3-hydroxymethylbutyl)guanine ([18F]FHBG) for gene therapy. Nucl Med Biol. 2001; 28: 875–883.
27. Buursma AR, Rutgers V, Hospers GAP, Mulder NH, Vaalburg W, de Vries EFJ. 18F-FEAU as a radiotracer for herpes simplex virus thymidine kinase gene expression: in-vitro comparison with other PET tracers. Nucl Med Commun. 2006; 27: 25–30.
28. Najjar AM, Nishii R, Maxwell DS, Volgin A, Mukhopadhyay U, Bornmann WG, et al. Molecular-genetic PET imaging using an HSV1-tk mutant reporter gene with enhanced specificity to acycloguanosine nucleoside analogs. J Nucl Med. 2009; 50: 409–416.
29. Yaghoubi SS, Gambhir SS. Measuring herpes simplex virus thymidine kinase reporter gene expression in vitro. Nat Protoc. 2006; 1: 2137–2142.
30. Yaghoubi SS, Gambhir SS. PET imaging of herpes simplex virus type 1 thymidine kinase (HSV1-tk) or mutant HSV1-sr39tk reporter gene expression in mice and humans using [18F]FHBG. Nat Protoc. 2007; 1: 3069–3075.
31. Yaghoubi SS, Berger F, Gambhir SS. Studying the biodistribution of positron emission tomography reporter probes in mice. Nat Protoc. 2007; 2: 1752–1755.
32. Alauddin MM, Shahinian A, Gordon EM, Conti PS. Evaluation of F-18 9-(4-fluoro-3-hydroxymethylbutyl) guanine [F-18]FHBG as a PET imaging agent for gene expression in tumor bearing nude mice [Abstract #103]. J Nucl Med. 1999; 40: 26P.
33. Tjuvajev JG, Doubrovin M, Akhurst T, Cai S, Balatoni J, Alauddin MA, et al. Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression. J Nucl Med. 2002; 43: 1072–1083.
34. Zanzonico P, Koehne G, Gallardo HF, Doubrovin M, Doubrovina E, Finn R, et al. [131I]FIAU labeling of genetically transduced, tumor-reactive lymphocytes: cell-level dosimetry and dosedependent toxicity. Eur J Nucl Med Mol Imaging. 2006; 33: 988–997.
35. Chin FT, Namavari M, Levi J, Subbarayan M, Ray P, chen X, et al. Semiautomated radiosynthesis and biological evaluation of [18F]FEAU: a novel PET imaging agent for HSV1-tk/sr39tk reporter gene expression. Mol Imaging Biol. 2008; 10: 82–91.
36. Nimmagadda S, Mangner TJ, Douglas KA, Muzik O, Shields AF. Biodistribution, PET, and radiation dosimetry estimates of HSV1-tk gene expression imaging agent 1-2'-deoxy-2'-18Ffluoro- ?-D-arabinofuranosyl_-5-iodouracil in normal dogs. J Nucl Med. 2007; 48: 655–660.
37. Ahn H, Choi TH, De Castro K, Lee KC, Kim B, Moon BS, et al. Syntheis and evaluation of cis-1-[4-(hydroxymethyl)-2-cyclopenten-1-yl]5-[124I]iodouracil: a potential PET imaging agent foe HSV1-tk expression. J Med Chem. 2007; 50: 6032–6028.
38. Chacko A, Qu W, Kung HF. Synthesis and in vitro evaluation of 5-[18F]fluoroalkyl pyrimidine nucleosides for molecular imaging of Herpes Simplex virus type 1 thymidine kinase reporter gene expression. J Med Chem. 2008; 51: 5690–5701.
39. Johayem A, Raic-Malic S, Lazzati K, Schubiger PA, Scapozza L, Ametamey SM. Synthesis and characterization of a C(6) nucleoside analogue for the in vivo imaging of the gene expression of Herpes Simplex virus type-1 thymidine kinase. Chemistry and Biodiversity. 2006; 3: 274–282.
40. Penuelas I, Haberkorn U, Yaghoubi S, Gambhir S. Gene therapy imaging in patients for oncological applications. Eur J Nucl Med Mol Imaging. 2005; 32: S384–S403.
41. Penuelas I, Mazzolini G, Boan JF, Sangro B, Marti-Climent J, Ruiz M, et al. Positron emission tomography imaging of adenoviral-mediated transgene expression in liver cancer patients. Gastroenterology. 2005; 128: 1787–1795.
42. Yaghoubi SS, Barrio JR, Namavari M, Satyamurthy N, Phelps ME, Herschman HR, et al. Imaging progress of herpes simplex virus type 1 thymidine kinase suicide gene therapy in living subjects with positron emission tomography. Cancer Gene Ther. 2005; 12: 329–339.
43. Yaghoubi SS, Creusot RJ, Ray P, Fathman CG, Gambhir SS. Multimodality imaging of T-cell hybridoma trafficking in collagen-induced arthritic mice: image-based estimation of the number of cells accumulating in mouse paws. Journal of Biomedical Optics. 2007; 12: 064025_1–11.
44. Yaghoubi SS, Jensen MC, Satyamurthy N, Budhiraja S, Paik D, Czernin J, et al. Noninvasive detection of therapeutic cytolytic T cells with 18F-FHBG in a patient with glioma. Nat Clin Pract Oncol. 2009; 6: 53–58.
45. Yaghoubi SS, Wu L, Liang Q, Toyokuni T, Barrio JR, Namavari M, et al. Direct correlation between positron emission tomographic images of two reporter genes delivered by two distinct adenoviral vectors. Gene Ther. 2001; 8: 1072–1080.
46. Johnson M, Karanikolas BD, Priceman SJ, Powell R, Black ME, Wu HM, et al. Titration of variant HSV1-tk gene expression to determine the sensitivity of 18F-FHBG PET imaging in a prostate tumor. J Nucl Med. 2009; 50: 757–764.
47. Roelants V, Labar D, de Meester C, Havaux X, Tabilio A, Gambhir SS, et al. Comparison between adenoviral and retroviral vectors for the transduction of the thymidine kinase PET reporter gene in rat mesenchymal stem cells. J Nucl Med. 2008; 49: 1836–1844.
48. Kuruppu D, Brownell AL, Zhu A, Yu M, Wang X, Kulu Y, et al. Positron emission tomography of herpes simplex virus 1 oncolysis. Cancer Res. 2007; 67: 3295–3300.
49. Kesarwala AH, Prior JL, Sun J, Harpstrite SE, Sharma V, Piwnica-Worms D. Second-generation triple reporter for bioluminescence, micro-positron emission tomography, and fluorescence imaging. Mol Imaging. 2006; 5: 465–474.
50. Waerzeggers Y, Klein M, Miletic H, Himmelreich U, Li H, Monfared P, et al. Multimodal imaging of neural progenitor cell fate in rodents. Mol Imaging Biol. 2008; 7: 77–91.
51. Luker GD, Sharma V, Pica CM, Dahlheimer JL, Li W, Ochesky J, et al. Noninvasive imaging of protein-protein interactions in living animals. PNAS. 2002; 99: 6961–6966.
52. Richard J-C, Factor P, Welch LC, Schuster DP. Imaging the spatial distribution of transgene expression in the lungs with positron emission tomography. Gene Ther. 2003; 10: 2074–2080.
53. Jacobs AH, Rueger MA, Winkeler A, Li H, Vollmar S, Waerzeggers Y, et al. Imaging-guided gene therapy of experimental gliomas. Cancer Res. 2007; 67: 1706–1715.
54. Chang GY, Cao F, Krishnan M, Huang M, Li Z, Xie X, et al. Positron emission tomography imaging of conditional gene activation in the heart. J Mol Cell Cardiol. 2007; 43: 18–26.
55. Cao F, Lin S, Xie X, Ray P, Patel M, Zhang X, et al. In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery. Circulation. 2006; 113: 1005–1014.
56. Chen IY, Wu JC, Min J, Sundaresan G, Lewis X, Liang Q, et al. Micro-positron emission tomography imaging of cardiac gene expression in rats using bicistronic adenoviral vectormediated gene delivery. Circulation. 2004; 109: 1415–1420.
57. Deroose CM, De A, Loening AM, Chow PL, Ray P, Chatziioannou AF, et al. Multimodality imaging of tumor xenografts and metastases in mice with combined small-animal PET, smallanimal CT, and bioluminescence imaging. J Nucl Med. 2007; 48: 295–303.
58. Green LA, Yap C, Nguyen KN, Barrio JR, Namavari M, Satyamurthy N, et al. Indirect monitoring of endogenous gene expression by positron emission tomography (PET) imaging of reporter gene expression in transgenic mice. Mol Imaging Biol. 2002; 4: 71–81.
59. Kim S, Doudet DJ, Studenov AR, Nian C, Ruth TJ, Gambhir SS, et al. Quantitative micro positron emission tomography (PET) imaging for the in vivo determination of pancreatic islet graft survival. Nat Med. 2006; 12: 1423–1428.
60. Liang Q, Gotts J, Satyamurthy N, Barrio JR, Phelps ME, Gambhir SS, et al. Noninvasive, rePETitive, quantitative measurement of gene expression from a bicistronic message by positron emission tomography, following gene transfer with adenovirus. Mol Ther. 2002; 6: 73–82.
61. Pantuck AJ, Berger F, Zisman A, Nguyen D, Tso CL, Matherly J, et al. CL1-SR39: a noninvasive molecular imaging model of prostate cancer suicide gene therapy using positron emission tomography. J Urol. 2002; 168: 1193–1198.
62. Pantuck AJ, Matherly J, Zisman A, Nguyen D, Berger F, Gambhir SS, et al. Optimizing prostate cancer suicide gene therapy using herpes simplex virus thymidine kinase active site variants. Hum Gene Ther. 2002; 13: 777–789.
63. Sundaresan G, Paulmurugan R, Berger F, Stiles B, Nagayama Y, Wu H, et al. MicroPET imaging of Cre-loxP-mediated conditional activation of a herpes simplex virus type 1 thymidine kinase reporter gene. Gene Ther. 2004; 11: 609–618.
64. Sen L, Gambhir SS, Furukawa H, Stout DB, Lam AL, Laks H, et al. Noninvasive imaging of ex vivo intracoronarily delivered nonviral therapeutic transgene expression in heart. Mol Ther. 2005; 12: 49–57.
65. Yang H, Berger F, Tran C, Gambhir SS, Sawyers CL. MicroPET imaging of prostate cancer in LNCaP-sr39tk-gfp mouse xenografts. The Prostate. 2003; 55: 39–47.
66. Wu JC, Inubushi M, Sundaresan G, Schelbert HR, Gambhir SS. Positron emission tomog-raphy imaging of cardiac reporter gene expression in living rats. Circulation. 2002; 106: 180–183.
67. Xiong Z, Cheng Z, Zhang X, Patel M, Wu JC, Gambhir SS, et al. Imaging chemically modified adenovirus for targeting tumors expressing integrin avß3 in living mice with mutant herpes simplex virus type 1 thymidine kinase PET reporter gene. J Nucl Med. 2006; 47: 130–139.
68. Wang Y, Iyer M, Annala AJ, Chappell S, Mauro V, Gambhir SS. Noninvasive monitoring of target gene expression by imaging reporter gene expression in living animals using improved bicistronic vectors. J Nucl Med. 2005; 46: 667–674.
69. Wu JC, Chen IY, Wang Y, Tseng JR, Chhabra A, Salek M, et al. Molecular Imaging of the kinetics of vascular endothelial growth factor gene expression in ischemic myocardium. Circulation. 2004; 110: 685–691.
70. Wu JC, chen IY, Sundaresan G, Min J, De A, Qiao J, et al. Molecular imaging of cardiac cell transplantation in living animals using optical bioluminescence and positron emission tomography. Circulation. 2003; 108: 1302–1305.
71. Ray P, De A, Min J, Tsien RY, Gambhir SS. Imaging tri-fusion multimodality reporter gene expression in living subjects. Cancer Res. 2004; 64: 1323–1330.
72. Ray P, Tsien R, Gambhir SS. Construction and validation of improved triple fusion reporter gene vectors for molecular imaging of living subjects. Cancer Res. 2007; 67: 3085–3093.
73. Ray P, Wu AM, Gambhir SS. Optical bioluminescence and positron emission tomography imaging of a novel fusion reporter gene in tumor xenografts of living mice. Cancer Res. 2003; 63: 1160–1165.
74. Freytag SO, Barton KN, Brown SL, Narra V, Zhang Y, Tyson D, et al. Replication-comPETent adenovirus-mediated suicide gene therapy with radiation in a preclinical model of pancreatic cancer. Mol Ther. 2007; 15: 1600–1606.
75. Anton M, Wittermann C, Haubner R, Simoes M, Reder S, Essien B, et al. Coexpression of herpesviral thymidine kinase reporter gene and VEGF gene for noninvasive monitoring of therapeutic gene transfer: an in vitro evaluation J Nucl Med. 2004; 45: 1743–1746.
76. Tarantal AF, Lee CCI, Jimenez DF, Cherry SR. Fetal gene transfer using lentiviral vectors: in vivo detection of gene expression by microPET and optical imaging in fetal and infant monkeys. Hum Gene Ther. 2006; 17: 1254–1261.
77. Burton JB, Johnson M, Sato M, Koh SBS, Mulholland DJ, Stout D, et al. Adenovirus-mediated gene expression imaging to directly detect sentinel lymph node metastasis of prostate cancer. Nat Med. 2008; 14: 882–888.
78. Su H, Chang DS, Gambhir SS, Braun J. Monitoring the antitumor response of naive and memory CD8 T cells in RAG1-/- mice by positron-emission tomography. J Immunol. 2006; 176: 4459–4467
79. Kim YJ, Dubey P, Ray P, Gambhir SS, Witte ON. Multimodality imaging of lymphocytic migration using lentiviral-based transduction of a tri-fusion reporter gene. Mol Imaging Biol. 2004; 6: 331–340.
80. Lu Y, Dang H, Middleton B, Zhang Z, Washburn L, Stout DB, et al. Noninvasive imaging of islet grafts using positron-emission tomography. PNAS. 2006; 103: 11294–11299.
81. Su H, Forbes A, Gambhir SS, Braun J. Quantitation of cell number by a positron emission tomography reporter gene strategy. Mol Imaging Biol. 2004; 6: 139–148.
82. Shu CJ, Guo S, Kim YJ, Shelly SM, Nijagal A, Ray P, et al. Visualization of a primary antitumor immune response by positron emission tomography. PNAS. 2005; 102: 17412–17417.
83. Dubey P, Su H, Adonai N, Du S, Rosato A, Braun J, et al. Quantitative imaging of T cell antitumor response by positron-emission tomography. PNAS. 2003; 100: 1232–1237.
84. Cao F, Drukker M, Lin S, Sheikh A, Xie X, Li Z, et al. Molecular imaging of embryonic stem cell misbehavior and suicide gene ablation. Cloning and Stem Cells. 2007; 9: 107–117.
85. Tjuvajev JG, Finn R, Watanabe K, Joshi R, Oku T, Kennedy J, et al. Noninvasive imaging of Herpes Simplex virus thymidine kinase gene transfer and expression: a potential method for monitoring clinical gene therapy. Cancer Res. 1996; 56: 4087–4095.
86. Brader P, Kelly K, Gang S, Shah JP, Wong RJ, Hricak H, et al. Imaging of lymph node micrometastases using an oncolytic herpes virus and [18F]FEAU PET. PLOS ONE. 2009; 4: e4789.
87. Bennett JJ, Tjuvajev J, Johnson P, Doubrovin M, Akhurst T, Malholtra S, et al. Positron emission tomography imaging for herpes virus infection: implications for oncolytic viral treatments of cancer. Nat Med. 2001; 7: 859–863.
88. Jacobs A, Tjuvajev JG, Dubrovin M, Akhurst T, Balatoni J, Beattie B, et al. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic Herpes Simplex virus type 1 mutant vectors in vivo. Cancer Res. 2001; 61: 2983–2995.
89. Serganova I, Moroz E, Vider J, Gogiberidze G, Moroz M, Pillarsetty N, et al. Multimodality imaging of TGF-Beta signaling in breast cancer metastases. The FASEB Journal. 2009; 23: 2662–2672.
90. Doubrovin M, Ponomarev V, Beresten T, Balatoni J, Bornmann W, Finn R, et al. Imaging transcriptional regulation of p53-dependent genes with positron emission tomography in vivo. PNAS. 2001; 98: 9300–9305.
91. Fuqiu H, Deng X, Wen B, Liu Y, Sun X, Xing L, et al. Noninvasive molecular imaging of hypoxia in human xenografts: comparing hypoxia-induced gene expression with endogenous and exogenous hypoxia markers. Cancer Res. 2008; 68: 8597–8606.
92. Tjuvajev JG, Joshi A, Callegari J, Lindsley L, Joshi R, Balatoni J, et al. A general approach to the non-invasive imaging of transgenes using cis-linked herpes simplex virus thymidine kinase. Neoplasia. 1999; 1: 315–320.
93. Jacobs A, Voges J, Reszka R, Lercher M, Grossmann A, Kracht L, et al. Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas. Lancet. 2001; 358: 727–729.
94. Dempsey MF, Wyper D, Owens J, Pimlott S, Papanastassiou V, Patterson J, et al. Assessment of 123I-FIAU imaging of herpes simplex viral gene expression in the treatment of glioma. Nucl Med Commun. 2006; 27: 611–617.
95. Deng W, Yang WK, Lai W, Liu R, Hwang J, Yang D, et al. Non-invasive in vivo imaging with radiolabelled FIAU for monitoring cancer gene therapy using herpes simplex virus type 1 thymidine kinase and ganciclovir. Eur J Nucl Med Mol Imaging. 2004; 31: 99–109.
96. Tjuvajev JG, Stockhammer G, Desai R, Uehara H, Watanabe H, Gansbacher B, et al. Imaging the expression of transfected genes in vivo. Cancer Res. 1995; 55: 6126–6132.
97. Deng W, Wu C, Lee C, Yang WK, Wang H, Liu R, et al. Serial in vivo imaging of lung metastases model and gene therapy using HSV1-tk and Ganciclovir. J Nucl Med. 2006; 47: 877–884.
98. Wang H, Yu H, Liu R, Lin M, Gelovani JG, Hwang J, et al. Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring Herpes Simplex virus type 1 thymidine kinase and Ganciclovir prodrug activation gene therapy of cancer. J Nucl Med. 2006; 47: 1161–1171.
99. Koehne G, Doubrovin M, Doubrovina E, Zanzonico P, Gallardo HF, Ivanova A, et al. Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes. Nat Biotechnol. 2003; 21: 405–413.
100. Dobrenkov K, Olszewska M, Likar Y, Shenker L, Gunset G, Cai S, et al. Monitoring the efficacy of adoptively transferred prostate cancer-targeted human T lymphocytes with PET and bioluminescence imaging. J Nucl Med. 2008; 49: 1162–1170.
101. Tai JH, Nguyen B, Wells RG, Kovacs MS, McGirr R, Prato FS, et al. Imaging of gene expression in live pancreatic islet cell lines using dual-isotope SPECT. J Nucl Med. 2008; 49: 94–102.
102. Black ME, Kokoris MS, Sabo P. Herpes simplex virus-1 thymidine kinase mutants created by semi-random sequence mutagenesis improve prodrug-mediated tumor cell killing. Cancer Res. 2001; 61: 3022–3026.
103. Qasim W, Thrasher AJ, Buddle J, Kinnon C, Black ME, Gaspar HB. T cell transduction and suicide with an enhanced mutant thymidine kinase. Gene Ther. 2002; 9: 824–827.
104. Miyagawa M, Anton M, Haubner R, Simoes MV, Stadele C, Erhardt W, et al. PET of cardiac transgene expression: comparison of 2 approaches based on Herpesviral thymidine kinase reporter gene. J Nucl Med. 2004; 45: 1917–1923.
105. Miyagawa T, Gogiberidze G, Serganova I, Cai S, Balatoni JA, Thaler HT, et al. Imaging of HSV-tk reporter gene expression: comparison between [18F]FEAU, [18F]FFEAU, and other imaging probes. J Nucl Med. 2008; 49: 637–648.
106. Gambhir SS, Herschman HR, Cherry SR, Barrio JR, Satyamurthy N, Toyokuni T, et al. Imaging transgene expression with radionuclide imaging technologies. Neoplasia. 2000; 2: 118–138.
107. Ponomarev V, Doubrovin M, Shavrin A, Serganova I, Beresten T, Ageyeva L, et al. A humanderived reporter gene for noninvasive imaging in humans: mitochondrial thymidine kinase type 2. J Nucl Med. 2007; 48: 819–826.
108. Wang J, Eriksson S. Phosphorylation of the anti-hepatitis B nucleoside analog 1-(2'-deoxy-2'- fluoro-1-beta-D-arabinofuranosyl)-5-iodouracil (FIAU) by human cytosolic and mitochondrial thymidine kinase and implications for cytotoxicity. Antimicrob Agents Chemother. 1996; 40: 1555–1557.
109. Chitneni SK, Deroose CM, Balzarini J, Gijsbers R, Celen SJL, de Groot TJ, et al. Synthesis and preliminary evaluation of 18F- or 11C-labeled bicyclic nucleoside analogues as potential probes for imaging Varicella-Zoster virus thymidine kinase gene expression using positron emission tomography. J Med Chem. 2007; 50: 1041–1049.
110. Louie AY, Huber MM, Ahrens ET, Rothbacher U, Moats R, Jacobs RE, et al. In vivo visualization of gene expression using magnetic resonance imaging. Nat Biotechnol. 2000; 18: 321–325.
111. Gilad AA, Winnard Jr PT, Van Zijl PCM, Bulte JWM. Developing MR reporter genes: promises and pitfalls. NMR Biomed. 2007; 20: 275–290.
112. Celen S, Cleynhens J, Deroose C, De Groot T, Ibrahimi A, Gijsbers R, et al. Synthesis and biological evaluation of 11C-labeled Beta-galactosyl triazoles as potential PET tracers for in vivo LacZ reporter gene imaging. Bioorg Med Chem Lett. 2009; 17: 5117–5125.
113. MacLaren DC, Gambhir SS, Satyamurthy N, Barrio JR, Sharfstein S, Toyokuni T, et al. RePETitive, non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animals. Gene Ther. 1999; 6: 785–791.
114. Yu Y, Annala AJ, Barrio JR, Toyokuni T, Satyamurthy N, Namavari M, et al. Quantification of target gene expression by imaging reporter gene expression in living animals. Nat Med. 2000; 6: 933–937.
115. Sun X, Annala AJ, Yaghoubi SS, Barrio JR, Nguyen KN, Toyokuni T, et al. Quantitative imaging of gene induction in living animals. Gene Ther. 2001; 8: 1572–1579.
116. Liang Q, Satyamurthy N, Barrio JR, Toyokuni T, Phelps ME, Gambhir SS, et al. Noninvasive, quantitative imaging in living animals of a mutant dopamine D2 receptor reporter gene in which ligand binding is uncoupled from signal transduction. Gene Ther. 2001; 8: 1490–1498.
117. Hwang DW, Kang JH, Chang YS, Jeong JM, Chung J, Lee MC, et al. Development of a dual membrane protein reporter system using sodium iodide symporter and mutant dopamine D2 receptor transgenes. J Nucl Med. 2007; 48: 588–595.
118. Furukawa T, Lohith TG, Takamatsu S, Mori T, Tanaka T, Fujibayashi Y. Potential of the FES–hERL PET reporter gene system — Basic evaluation for gene therapy monitoring. Nucl Med Biol. 2006; 33: 145–151.
119. Lohith TG, Furukawa T, Mori T, Kobayashi M, Fujibayashi Y. Basic evaluation of FES-hERL PET tracer-reporter gene system for in vivo monitoring of adenoviral-mediated gene therapy. Mol Imaging Biol. 2008; 10: 245–252.
120. Chaudhuri TR, Rogers BE, Buchsbaum DJ, Mountz JM, Zinn KR. A noninvasive reporter system to image adenoviral-mediated gene transfer to ovarian cancer xenografts. Gynecol Oncol. 2001; 83: 432–438.
121. Zinn KR, chaudhuri TR, Buchsbaum DJ, Mountz JM, Rogers BE. Detection and measurement of in vitro gene transfer by gamma camera imaging. Gene Ther. 2001; 8: 291–299.
122. Zinn KR, Buchsbaum DJ, chaudhuri TR, Mountz JM, Grizzle WE, Rogers BE. Noninvasive monitoring of gene transfer using a reporter receptor imaged with a high-affinity peptide radiolabeled with 99mTc or 188Re. J Nucl Med. 2000; 41: 887–895.
123. Rogers BE, chaudhuri TR, Reynolds PN, Manna DD, Zinn KR. Non-invasive gamma camera imaging of gene transfer using an adenoviral vector encoding an epitope-tagged receptor as a reporter. Gene Ther. 2003; 10: 105–114.
124. Kenanova V, Barat B, Olafsen T, chatziioannou A, Herschman HR, Braun J, et al. Recombinant carcinoembryonic antigen as a reporter gene for molecular imaging. Eur J Nucl Med Mol Imaging. 2009; 36: 104–114.
125. Wei LH, Olafsen T, Radu CG, Hildebrandt IJ, McCoy MR, Phelps ME, et al. Engineered antibody fragments with infinite affinity as reporter genes for PET imaging. J Nucl Med. 2008; 49: 1828–1835.
126. Chung J. Sodium iodide symporter: its role in nuclear medicine. J Nucl Med. 2002; 43: 1188–1200.
127. Haberkorn U. Gene Therapy with sodium/iodide symporter in hepatocarcinoma. Experimental and Clinical Endocrinology & Diabetes. 2001; 109: 60–62.
128. Cho J-Y, Shen DHY, Yang W, Williams B, Buckwalter TLF, La Perle KMD, et al. In vivo imaging and radioiodine therapy following sodium iodide symporter gene transfer in animal model of intracerebral gliomas. Gene Ther. 2002; 9: 1139–1145.
129. Cho J-Y. A transporter gene (sodium iodide symporter) for dual purposes in gene therapy: imaging and therapy. Curr Gene Ther. 2002; 2: 393–402.
130. Goel A, Carlson SK, Classic KL, Greiner S, Naik S, Power AT, et al. Radioiodide imaging and radiovirotherapy of multiple myeloma using VSV(delta51)-NIS, an attenuated vesicular stomatitis virus encoding the sodium iodide symporter gene. Blood. 2007; 110: 2342–2350.
131. Groot-Wassink T, Aboagye EO, Wang Y, Lemoine NR, Reader AJ, Vassaux G. Quantitative imaging of Na/I symporter transgene expression using positron emission tomography in the living animal. Mol Ther. 2004; 9: 436–442.
132. Shin JH, chung J, Kang JH, Lee YJ, Kim K, Kim CW, et al. Feasibility of sodium/iodide symporter gene as a new imaging reporter gene: comparison with HSV1-tk. Eur J Nucl Med Mol Imaging. 2004; 31: 425–432.
133. Lim SJ, Paeng JC, Kim SJ, Kim SY, Lee H, Moon DH. Enhanced expression of adenovirusmediated sodium iodide symporter gene in MCF-7 breast cancer cells with retinoic acid treatment. J Nucl Med. 2007; 48: 398–404.
134. Yoon J, Park B, Paik J, Jung K, Ko B, Lee K. Effects of theophylline on radioiodide uptake in MCF-7 breast cancer and NIS gene-transduced SNU-C5 colon cancer cells. Cancer Biotherapy and Radiopharmaceuticals. 2009; 24: 201–208.
135. Moroz MA, Serganova I, Zanzonico P, Ageyeva L, Beresten T, Dyomina E, et al. Imaging hNET reporter gene expression with 124I-MIBG. J Nucl Med. 2007; 48: 827–836.
136. Yaghoubi SS, Gambhir SS. Gene therapy and imaging of transgene expression in living subjects. In: Yaghoubi SS, Gambhir SS, editors. Molecular Imaging With Reporter Genes: Cambridge University Press; 2010. p. 227–238.
137. Ray P, Bauer E, Iyer M, Barrio JR, Satyamurthy N, Phelps ME, et al. Monitoring gene therapy with reporter gene imaging. Semin Nucl Med. 2001; 31: 312–320.
138. Iyer M, Sato M, Johnson M, Gambhir SS, Wu L. Applications of molecular imaging in cancer gene therapy. Curr Gene Ther. 2005; 5: 607–618.
139. Blasberg RG, Gelovani-Tjuvajev J. In vivo molecular-genetic imaging. J Cell Biochem. 2002; 39: 172–183.
140. Herschman HR, Barrio JR, Satyamurthy N, Liang Q, MacLaren DC, Yaghoubi S, et al. Monitoring gene therapy by positron emission tomography. In: Curiel DT, Douglas JT, eds. Vector Targeting for Therapeutic Gene Delivery. New York: Wiley-Liss, Inc.; 2002.
141. Yaghoubi S. Imaging reporter transgene expression in living subjects using positron emission tomography [Dissertation]. Los Angeles: University of California, Los Angeles; 2002.
142. Ray P, Gambhir SS. Multimodality imaging of reporter genes. In: Yaghoubi SS, Gambhir SS, eds. Molecular Imaging With Reporter Genes. Cambridge University Press, 2010; p. 113–126.
143. Jacobs A, Dubrovin M, Hewett J, Sena-Esteves M, Tan CW, Slack M, et al. Functional coexpression of HSV-1 thymidine kinase and green fluorescent protein: implications for noninvasive imaging of transgene expression. Neoplasia. 1999; 1: 154–161.
144. Ponomarev V, Doubrovin M, Serganova I, Vider J, Shavrin A, Beresten T, et al. A novel triplemodality reporter gene for whole-body fluorescent, bioluminescent, and nuclear noninvasive imaging. Eur J Nucl Med Mol Imaging. 2004; 31: 740–751.
145. Kuruppu D, Tanabe KK. Viral oncolysis by herpes simplex virus and other viruses. Cancer Biology and Therapy. 2005; 4: 524–531.
146. Fu D, Tanhehco YC, Chen J, Foss CA, Fox JJ, Lemas V, et al. Virus-associated tumor imaging by induction of viral gene expression. Clin Cancer Res. 2007; 13: 1453–1458.
147. Brader P, Kelly KJ, Chen N, Yu YA, Zhang Q, Zanzonico P, et al. Imaging a genetically engineered oncolytic vaccinia virus (GLV-1h99) using a human norepinephrine transporter reporter gene. Clin Cancer Res. 2009; 15: 3791–3801.
148. Merron A, Peerlinck I, Martin-Duque P, Burnet J, Quintanilla M, Mather S, et al. SPECT/CT imaging of oncolytic adenovirus propagation in tumours in vivo using the Na/I symporter as a reporter gene. Gene Ther. 2007; 14: 1731–1738.
149. Carlson SK, Classic KL, Hadac EM, Dingli D, Bender CE, Kemp BJ, et al. Quantitative molecular imaging of viral therapy for pancreatic cancer using an engineered measles virus expressing the sodium-iodide symporter reporter gene. Am J Roentgenol. 2009; 192: 279–287.
150. Padmanabhan P, Otero J, Ray P, Paulmurugan R, Hoffman AR, Gambhir SS, et al. Visualization of telomerase reverse transcriptase (hTERT) promoter activity using a trimodality fusion reporter construct. J Nucl Med. 2006; 47: 270–277.
151. Kang HJ, Chung J, Lee YJ, Kim K, Jeong JM, Lee DS, et al. Evaluation of transcriptional activity of the oestrogen receptor with sodium iodide symporter as an imaging reporter gene. Nucl Med Commun. 2006; 27: 773–777.
152. Akins EJ, Dubey P. Noninvasive imaging of cell-mediated therapy for treatment of cancer. J Nucl Med. 2008; 49: 180S–195S.
153. Rogers WJ, Meyer CH, Kramer CM. Technology insight: in vivo cell tracking by use of MRI. Nature Clinical Practice Cardiovascular Medicine. 2006; 3: 554–562.
154. Hardy J, Edinger M, Bachmann MH, Negrin RS, Fathman CG, Contag C. Bioluminescence imaging of lymphocyte trafficking in vivo. Exp Hematol. 2001; 29: 1353–1360.
155. Acton PD, Zhou R. Imaging reporter genes for cell tracking with PET and SPECT. Quarterly Journal of Nuclear Medicine and Molecular Imaging. 2005; 49: 349–360.
156. Bengel FM. Nuclear imaging in cardiac cell therapy. Heart Failure Reviews. 2006; 11: 325–332.
157. Lucignani G, Ottobrini L, Martelli C, Rescigno M, Clerici M. Molecular imaging of cellmediated cancer immunotherapy. Trends Biotechnol. 2006; 24: 410–418.
158. Arbab AS, Janic B, Haller J, Pawelczyk E, Liu W, Frank JA. In vivo cellular imaging for translational medical research. Current Medical Imaging Reviews. 2009; 5: 19–38.
159. Morse MA, Coleman RE, Akabani G, Niehaus N, Coleman D, Lyerly HK. Migration of human dendritic cells after injection in patients with metastatic malignancies. Cancer Res. 1999; 59: 56–58.
160. Ahrens ET, Flores R, Xu H, Morel PA. In vivo imaging platform for tracking immunotherapeutic cells. Nat Biotechnol. 2005; 23: 983–987.
161. De Vries IJM, Lesterhuis WJ, Barentsz JO, Verdijk P, Van Krieken JH, Boerman OC, et al. Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat Biotechnol. 2005; 23: 1407–1413.
162. Austyn JM, Kupiec-Weglinski JW, Hankins DF, Morris PJ. Migration patterns of dendritic cells in the mouse: homing to T cell-dependent areas of spleen and binding within marginal zone. J Exp Med. 1988; 167: 646–651.
163. Olasz EB, Lang L, Seidel J, Green MV, Eckelman WC, Katz SI. Fluorine-18 labeled mouse bone marrow-derived dendritic cells can be detected in vivo by high resolution projection imaging. J Immunol Methods. 2002; 260: 137–148.
164. Stuckey DJ, Carr CA, Martin-Rendon E, Tyler DJ, Willmott C, Cassidy PJ, et al. Iron particles for noninvasive monitoring of bone marrow stromal cell engraftment into, and isolation of viable engrafted donor cells from, the heart. Stem Cells. 2006; 24: 1968–1975.
165. Michalet X, Pinaud FF, Bentolila LA, Tsay JM, Doose S, Li JJ, et al. Quantum dots for live cells, in vivo imaging and diagnostics. Science. 2005; 307: 538–544.
166. Stodilka RZ, Blackwood KJ, Prato FS. Tracking transplanted cells using dual-radionuclide SPECT. Phys Med Biol. 2006; 51: 2619–2632.
167. Kircher MF, Allport JR, Graves EE, Love V, Josephson L, Lichtman AH, et al. In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors. Cancer Res. 2003; 63: 6838–6846.
168. Evgenov NV, Medarova Z, Pratt J, Pantazopoulos P, Leyting S, Bonner-Weir S, et al. In vivo imaging of immune rejection in transplanted pancreatic islets. Diabetes. 2006; 55: 2419–2428.
169. Vuu K, Xie J, McDonald MA, Bernardo M, Hunter F, Zhang Y, et al. Gadolinium-Rhodamine nanoparticles for cell labeling and tracking via magnetic resonance and optical imaging. Bioconjug Chem. 2005; 16: 995–999.
170. Adonai N, Nguyen KN, Walsh J, Iyer M, Toyokuni T, Phelps ME, et al. Ex vivo cell labeling with 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography. PNAS. 2002; 99: 3030–3035.
171. Doubrovin MM, Doubrovina E, Zanzonico P, Sadelain M, Larson SM, O’Reilly RJ. In vivo imaging and quantitation of adoptively transferred human antigen-specific T cells transduced to express a human norepinephrine transporter gene. Cancer Res. 2007; 67: 11959–11969.
172. Lo W, Hsu C, Wu ATH, Yang L, Chen W, Chiu W, et al. A novel cell-based therapy for contusion spinal cord injury using GDNF-delivering NIH3T3 cells with dual reporter genes monitored by molecular imaging. J Nucl Med. 2008; 49: 1512–1519.
173. Dotti G, Tian M, Savoldo B, Najjar A, Cooper LJN, Jackson J, et al. RePETitive noninvasive monitoring of HSV1-tk-expressing T cells intravenously infused into nonhuman primates using positron emission tomography and computed tomography with 18F-FEAU. Mol Imaging. 2009; 8: 230–237.
174. Kim D, Hung C, Wu T-C. Monitoring the trafficking of adoptively transferred antigen-specific CD8-positive T cells in vivo, using non-invasive luminescence imaging. Hum Gene Ther. 2007; 18: 575–588.
175. Cao Y, Bachmann MH, Beilhack A, Yang Y, Tanaka M, Swijnenburg R, et al. Molecular imaging using labeled donor tissues reveals patterns of engraftment, rejection and survival in transplantation. Transplantation. 2005; 80: 134–139.
176. Schimmelpfennig CH, Schulz S, Arber C, Baker J, Tarner IH, McBride J, et al. Ex vivo expanded dendritic cells home to T-cell zones of lymphoid organs and survive in vivo after allogeneic bone marrow transplantation. Am J Pathol. 2005; 167: 1321–1331.
177. Tolar J, Osborn M, Bell S, McElmurry R, Xia L, Riddle M, et al. Real-time in vivo imaging of stem cells following transgenesis by transposition. Mol Ther. 2005; 12: 42–48.
178. Terrovitis J, Kwok KF, Lautamaki R, Engles JM, Barth AS, Kizana E, et al. Ectopic expression of the sodium-iodide symporter enables imaging of transplanted cardiac stem cells in vivo by single-photon emission computed tomography or positron emission tomography. J Am Coll Cardiol. 2008; 52: 1652–1660.
179. Qiao H, Surti S, Choi SR, Raju K, Zhang H, Ponde DE, et al. Death and Proliferation Time Course of Stem Cells Transplanted in the Myocardium. Mol Imaging Biol. 2009; 11: 408–414.
180. Willmann JK, Paulmurugan R, Rodriguez-Porcel M, Stein W, Brinton TJ, Connolly AJ, et al. Imaging gene expression in human mesenchymal stem cells: from small to large animals. Radiology. 2009; 252: 117–127.
181. Hwang DW, Kang JH, Jeong JM, Chung J, Lee MC, KIm S, et al. Noninvasive in vivo monitoring of neuronal differentiation using reporter driven by a neuronal promoter. Eur J Nucl Med Mol Imaging. 2008; 35: 135–145.
182. Wu JC, Cao F, Dutta S, Xie X, Kim E, Chungfat N, et al. Proteomic analysis of reporter genes for molecular imaging of transplanted embryonic stem cells. Proteomics. 2006; 6: 6234–6249.
183. Wang F, Dennis JE, Awadallah A, Solchaga LA, Molter J, Kuang Y, et al. Transcriptional profiling of human mesenchymal stem cells transduced with reporter genes for imaging. Physiol Genomics. 2009; 37: 23–34.
184. Matsui K, Wang Z, McCarthy TJ, Allen PM, Reichert DE. Quantitation and visualization of tumor-specific T cells in the secondary lymphoid organs during and after tumor elimination by PET. Nucl Med Biol. 2004; 31: 1021–1031.
185. Annovazzi A, D’Alessandria C, Bonanno E, Mather SJ, Cornelissen B, Van de Wiele C, et al. Synthesis of 99mTc-HYNIC-interleukin-12, a new specific radiopharmaceutical for imaging T lymphocytes. Eur J Nucl Med Mol Imaging. 2006; 33: 474–482.
186. Malviya G, D’ Alessandria C, Bonanno E, Vexler V, Massari R, Trotta C, et al. Radiolabeled humanized anti-CD3 monoclonal antibody Visilizumab for imaging human T-lymphocytes. J Nucl Med. 2009; 50: 1683–1691.
187. Massoud TF, Gambhir SS. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev. 2003; 17: 545–580.
188. Peñuelas I, Yaghoubi SS, Prósper F, Gambhir SS. Clinical applications of reporter gene technology. In: Yaghoubi SS, Gambhir SS, editors. Molecular Imaging With Reporter Genes: Cambridge University Press, 2010; p. In Press.
189. Barton KN, Stricker H, Brown SL, Elshaikh M, Aref I, Lu M, et al. Phase I study of noninvasive imaging of adenovirus-mediated gene expression in the human prostate. Mol Ther. 2008; 16: 1761–1769.
190. Figueiredo ML, Gambhir SS, Carey M, Wu L. Cell-specific imaging of reporter gene expression using a two-step transcriptional amplification strategy. In: Yaghoubi SS, Gambhir SS, editors. Molecular Imaging With Reporter Genes: Cambridge University Press, 2010; pp. 127–148.